Manufacturer
Pfizer NDC Codes
Finished products listed with the FDA under labeler names that contain “Pfizer”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Cutaquigimmunoglobulin g | Human immunoglobulin g 165 mg/mL | SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1965 |
| Cyklokaprontranexamic acid | Tranexamic acid 100 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0013-1114 |
| Cytomelliothyronine sodium | Liothyronine sodium 5 ug/1 | TabletOral | Pfizer Laboratories Div Pfizer Inc | 60793-115 |
| Cytomelliothyronine sodium | Liothyronine sodium 25 ug/1 | TabletOral | Pfizer Laboratories Div Pfizer Inc | 60793-116 |
| Cytomelliothyronine sodium | Liothyronine sodium 50 ug/1 | TabletOral | Pfizer Laboratories Div Pfizer Inc | 60793-117 |
| Cytotecmisoprostol | Misoprostol 100 ug/1 | TabletOral | Pfizer Laboratories Div Pfizer Inc | 0025-1451 |
| Cytotecmisoprostol | Misoprostol 200 ug/1 | TabletOral | Pfizer Laboratories Div Pfizer Inc | 0025-1461 |
| Daurismoglasdegib | Glasdegib 25 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-0298 |
| Daurismoglasdegib | Glasdegib 100 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-1531 |
| Dilantin Infatabsphenytoin | Phenytoin 50 mg/1 | Tablet, ChewableOral | Parke-Davis Div of Pfizer Inc | 0071-0007 |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-0255 |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-0277 |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-0343 |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-0358 |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-1442 |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-1542 |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-3358 |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-4031 |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-4205 |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-5629 |
| Duaveeconjugated estrogens/bazedoxifene | Estrogens, Conjugated .45 mg/1; Bazedoxifene acetate 20 mg/1 | Tablet, Film coatedOral | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 0008-1123 |
| Elelysotaliglucerase alfa | Taliglucerase alfa 200 U/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-0106 |
| Elrexfioelranatamab-bcmm | Elranatamab 44 mg/1.1mL | Injection, SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-2522 |
| Elrexfioelranatamab-bcmm | Elranatamab 76 mg/1.9mL | Injection, SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-4494 |
| Estringestradiol | Estradiol 2 mg/1 | SystemVaginal | Pfizer Laboratories Div Pfizer Inc | 0013-1042 |